Franklin Biotechnology Discovery Fund Class A (FBDIX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD

209.75

-1.42 (-0.67%)

At close: Aug 26, 2026

59.43% (1Y)

Fund Assets	1.15B
Expense Ratio	1.02%
Min. Investment	$1,000
Turnover	37.62%
Dividend (ttm)	3.50
Dividend Yield	1.68%
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 22, 2025

Previous Close	211.17
YTD Return	26.55%
1-Year Return	76.41%
5-Year Return	73.15%
52-Week Low	133.56
52-Week High	213.76
Beta (5Y)	0.58
Holdings	119
Inception Date	Sep 15, 1997

About FBDIX

Franklin Biotechnology Discovery Fund Class A is a mutual fund that seeks capital appreciation by investing at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The fund focuses on companies involved in genomics, genetic engineering, gene therapy, pharmaceuticals, and related health care sectors. With a portfolio heavily weighted toward biotechnology and pharmaceutical industries, the fund aims to capitalize on innovations in cell and gene therapies, specialty drugs for rare diseases, and advanced treatment platforms. The fund maintains a diversified approach across approximately 80 biotechnology and pharmaceutical issuers, providing exposure to the evolving landscape of medical breakthroughs and therapeutic advancements. Managed by an experienced team since its inception, the fund distributes dividends annually and is designed for investors seeking long-term growth through participation in the biotechnology and life sciences sectors.

Fund Family Franklin Templeton Investments

Category Health

Performance Rating Above Average

Risk Rating Above Average

Stock Exchange NASDAQ

Ticker Symbol FBDIX

Share Class Class A

Index NASDAQ Biotechnology CR

Performance

FBDIX had a total return of 76.41% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.58%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
FRBRX	Class R6	0.67%
FTDZX	Advisor Class	0.77%
FBTDX	Class C	1.77%

Top 10 Holdings

35.61% of assets

Name	Symbol	Weight
Jazz Pharmaceuticals plc	JAZZ	5.65%
Amgen Inc.	AMGN	4.39%
Gilead Sciences, Inc.	GILD	3.85%
Regeneron Pharmaceuticals, Inc.	REGN	3.76%
argenx SE	ARGX	3.62%
Vertex Pharmaceuticals Incorporated	VRTX	3.54%
Revolution Medicines, Inc.	RVMD	3.01%
Guardant Health, Inc.	GH	2.76%
Ascendis Pharma A/S	ASND	2.56%
Oruka Therapeutics, Inc.	ORKA	2.47%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 22, 2025	$17.9181	Dec 22, 2025
Dec 20, 2024	$11.7607	Dec 20, 2024
Dec 20, 2022	$0.1411	Dec 20, 2022
Dec 15, 2021	$17.6831	Dec 15, 2021
Dec 15, 2020	$10.3921	Dec 15, 2020
Dec 16, 2019	$14.1643	Dec 18, 2019

Full Dividend History